Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2026-05-07 @ 4:37 PM
Study NCT ID:
NCT07216066
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-10-14
First Post:
2025-10-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Sponsor:
Regeneron Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Parkinsons Disease | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Early Parkinsons disease | View |
| None | Motor and non-motor brain systems | View |
| None | Bradykinesia plus | View |
| None | Resting tremor | View |
| None | Rigidity | View |
| None | Postural instability | View |
| None | Cognitive impairment | View |
| None | Mood disorders | View |
| None | Sleep disturbances | View |
| None | Autonomic dysfunction | View |